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Malaria is a serious mosquito-borne disease caused by a
protozoan parasite. Vaccines can target different stages of
the pathogen’s life cycle. Transmission blocking vaccines
target mosquito stages of the parasite life cycle, and will
support eradication programs to ease the disease burden
at the population level. Pfs25 is a sexual stage protein of
Plasmodium falciparum which is found on the surface of
the parasite zygote as it develops in the mosquito midgut.
Antibodies against this protein block zygote development,
and as a result block transmission to the next human host.
Pfs25 was successfully expressed in our plant-based launch
vector system as a fusion to the lichenase carrier molecule
and as a fusion to the Alfalfa mosaic virus coat protein
(AIMV CP), and in each case was purified to a high level
of homogeneity. The resulting Pfs25-lichenase and Pfs25-
AIMVCP antigens have undergone extensive biochemical
characterization and dose-ranging studies in pre-clinical
animal models, where both antigens induced transmission
blocking antibodies. These data demonstrate the feasibility
of expressing Plasmodium antigens in a plant-based sys-
tem for the economical production of a transmission-
blocking vaccine against malaria.
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